top of page

Search


SME Hiring Strategy: Why You Can’t Afford “Maybe” People When Every Seat Matters
Every seat in your SME either multiplies your momentum or magnifies your mistakes. When your team is small, one person’s performance, attitude, and alignment impact everyone. A single mis-hire can slow down key projects, drain your best talent’s energy, and introduce silent dysfunction into your culture. 👉 Most founders don’t hire bad people. They hire “maybe” people , candidates who seem capable, but lack the mindset, initiative, or fit to truly contribute at the level yo

Attila Foris
Oct 276 min read


Scaling Framework for Biotech: The 3 Blind Spots That Stall Growth
Most biotech CEOs fail not on science, but on scale. This expanded framework reveals the three blind spots—pipeline chaos, headcount traps, and investor readiness—that stall growth.

Attila Foris
Oct 143 min read


Scaling Biotech Operations: Investors Now Judge Execution, Not Just Science
Investors in 2025 aren’t just backing biotech science—they’re judging execution. CEOs who can’t show scaling signals—operational rhythm, cross-team clarity, and a real scalability narrative—risk burning credibility, not just capital. This memo breaks down the three signals biotech leaders must master to win trust and funding.

Attila Foris
Oct 12 min read


Intentional Networking for Entrepreneurs: Why the 3 P’s and 3 C’s Outperform Traditional Approaches
If you’re an entrepreneur, you’ve probably heard countless times that you need to network more. Investors remind you. Advisors insist on...

Attila Foris
Sep 86 min read
bottom of page
